Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacovigilance. The French system.

R J Royer1

  • 1French National Committee for Pharmacovigilance, Centre Hospitalier Régional, Universitaire de Nancy, France.

Drug Safety
|January 1, 1990
PubMed
Summary

France

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mechanism of action of adverse drug reactions: an overview.

Pharmacoepidemiology and drug safety·2004
Same author

The link between sunshine and phototoxicity of sparfloxacin.

British journal of clinical pharmacology·2000
Same author

[Tomorrow's drug surveillance].

Therapie·2000
Same author

First Congress of the European Association for Clinical Pharmacology and Therapeutics.

Therapie·1996
Same author

Adverse drug reactions with fluoroquinolones.

Therapie·1996
Same author

Tendon disorders with fluoroquinolones.

Therapie·1996

Area of Science:

  • Pharmacovigilance and drug safety monitoring.
  • Public health and pharmaceutical regulation.

Background:

  • The French drug surveillance system integrates mandatory reporting and hospital-based monitoring.
  • Decentralized Regional Centres form a coordinated national network for pharmacovigilance.

Purpose of the Study:

  • To describe the structure and function of the French pharmacovigilance system.
  • To highlight methods for assessing drug-adverse effect relationships and alerting healthcare professionals.

Main Methods:

  • Utilizing an algorithm index to evaluate drug-adverse effect causality.
  • Compiling and analyzing case reports from a national data bank (8062 cases in 1988).
  • Analyzing queries from general practitioners (20,000 in 1988) for adverse reaction signals.

Main Results:

  • The system processed a significant volume of data, including numerous case reports and practitioner queries.
  • An established algorithm index aids in identifying potential drug-related adverse effects.

Conclusions:

  • The French pharmacovigilance system effectively collects and analyzes data to monitor drug safety.
  • Key functions include information dissemination, data analysis, and promoting safe medication use.

Related Experiment Videos